The Medication Pass: An Evidence-Based and Person-Centered Approach to Improving EfficiencySeptember 15, 2022
Jeff Herr, Pharm D, Manager of Clinical Operations, PharMerica
Bill Vaughan, RN, BSN, Consultant, NADONA
Date: Thursday, September 15, 2022 1:00pm ET
- Describe two factors to consider when deciding the frequency of monitoring drugs as required at F757(Unnecessary Drugs)
- Identify two regulatory “myths” which can adversely impact the efficiency of the medication pass.
- List three rescue/antidote medications which must be readily available in a Long-Term Care facility.
- Describe the process of optimizing the interim drug supply and its impact on the efficiency of the medication pass.
Free 1 CEU for NAB and Nursing Credit Available (must be in attendance)